Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge
Authors:
Open Access
- 15 January 2024
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 237, 205-208
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund (F 5409-B21)
This publication has 12 references indexed in Scilit:
- Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In VivoThrombosis and Haemostasis, 2020
- Endogenous Thrombospondin-1 Regulates Leukocyte Recruitment and Activation and Accelerates Death from Systemic CandidiasisPLOS ONE, 2012
- von Willebrand Factor: More Than a Regulator of Hemostasis and ThrombosisActa Haematologica, 2012
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammationThrombosis and Haemostasis, 2005
- Plasma levels of von Willebrand factor regulate ADAMTS‐13, its major cleaving proteaseBritish Journal of Haematology, 2004
- Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemiaBlood, 2003
- Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungsJournal of Clinical Investigation, 2003
- Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humansBlood, 1996
- A Comparative Study Using Immunological and Biological Assays of the Haemostatic Responses to DDAVP Infusion Venous Occlusion and Exercise in Normal MenThrombosis and Haemostasis, 1984